“…Thirdly, not only age but also pubertal stage related, laboratory specific normative data should be used. Further, testes sparing enucleation of a Leydig-cell tumour seems to be sufficient in childhood, but the boy’s scrotum and further development needs ongoing follow-up as rarely a malignant process may occur in the future [23]. In addition, considering the previously reported mutations found in a few of Leydig-cell tumours [3,4,5,6,7,8,9,10,11], the absence of any activating mutations in LHR , as well as in both the ‘hot spot’ regions within the G-alpha subunits ( gsp and gip2 ) and in the regulatory ‘hot spot’ of the CDK4 genes in our patients, indicates molecular heterogeneity among Leydig-cell tumours, corresponding to its highly variable phenotype, which has not been reported previously.…”